Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions - PubMed

Affiliations

• PMID: 12952598
• DOI: 10.1089/104303403767740803

Comparative Study

Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions

Hiroyuki Mizuguchi et al. Hum Gene Ther. 2003.

Abstract

We previously developed single adenovirus (Ad) vectors that contained the components for a tetracycline-regulatable gene-expression system in the E1 and E3 deletion regions, and showed that the Ad vectors containing the tet-on system exhibit a much inferior regulation of transgene expression than those containing the tet-off system. In many cases, the tet-on system may be preferable because of its positive regulation of transgene expression. To this end, in the present study, by introducing the latest generation reverse tetracycline-responsive transcriptional activator (rtTA2s-M2 or rtTA2s-S2) and the tetracycline-controlled transcriptional silencer (tTS) into the original tet-on system, we constructed various modified Ad-mediated tet-on systems. Among them, the novel single Ad vector, which contained three heterologous gene-expression cassettes of the gene of interest, rtTA2s-S2, and tTS in the E1 deletion region, the E3 deletion region, and the region between E4 and 3'ITR, respectively, displayed vastly improved doxycycline-inducible gene expression in terms of low basal expression, high induced expression, and high responsiveness to doxycycline both in vitro and in vivo. These results also suggest that the low responsiveness to doxycycline may explain why the original tet-on system in the context of the Ad vector is not effective in vivo. This is the first report describing the cloning of three heterologous gene-expression cassettes into three separate regions of the E1/E3-deleted Ad genome. This improved Ad-mediated tet-on system might be useful for gene therapy and greatly facilitate the analyses of gene function.

Similar articles

• The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector.

  Mizuguchi H, Hayakawa T. Mizuguchi H, et al. J Gene Med. 2002 May-Jun;4(3):240-7. doi: 10.1002/jgm.261. J Gene Med. 2002. PMID: 12112641

• Characteristics of adenovirus-mediated tetracycline-controllable expression system.

  Mizuguchi H, Hayakawa T. Mizuguchi H, et al. Biochim Biophys Acta. 2001 Nov 7;1568(1):21-9. doi: 10.1016/s0304-4165(01)00195-7. Biochim Biophys Acta. 2001. PMID: 11731081

• New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo.

  Rubinchik S, Woraratanadharm J, Yu H, Dong JY. Rubinchik S, et al. Gene Ther. 2005 Mar;12(6):504-11. doi: 10.1038/sj.gt.3302437. Gene Ther. 2005. PMID: 15660114

• Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling.

  Zhu Z, Zheng T, Lee CG, Homer RJ, Elias JA. Zhu Z, et al. Semin Cell Dev Biol. 2002 Apr;13(2):121-8. doi: 10.1016/s1084-9521(02)00018-6. Semin Cell Dev Biol. 2002. PMID: 12127145 Review.

• Optimizing regulatable gene expression using adenoviral vectors.

  Lee YB, Glover CP, Cosgrave AS, Bienemann A, Uney JB. Lee YB, et al. Exp Physiol. 2005 Jan;90(1):33-7. doi: 10.1113/expphysiol.2004.028209. Epub 2004 Nov 12. Exp Physiol. 2005. PMID: 15542617 Review.

Cited by

• Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.

  Bornkamm GW, Berens C, Kuklik-Roos C, Bechet JM, Laux G, Bachl J, Korndoerfer M, Schlee M, Hölzel M, Malamoussi A, Chapman RD, Nimmerjahn F, Mautner J, Hillen W, Bujard H, Feuillard J. Bornkamm GW, et al. Nucleic Acids Res. 2005 Sep 7;33(16):e137. doi: 10.1093/nar/gni137. Nucleic Acids Res. 2005. PMID: 16147984 Free PMC article.

• Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells.

  Harms JS, Eakle KA, Kuo LS, Bremel RD, Splitter GA. Harms JS, et al. Genet Vaccines Ther. 2004 Aug 24;2(1):11. doi: 10.1186/1479-0556-2-11. Genet Vaccines Ther. 2004. PMID: 15327692 Free PMC article.

• In vivo gene regulation using tetracycline-regulatable systems.

  Stieger K, Belbellaa B, Le Guiner C, Moullier P, Rolling F. Stieger K, et al. Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):527-41. doi: 10.1016/j.addr.2008.12.016. Epub 2009 Apr 23. Adv Drug Deliv Rev. 2009. PMID: 19394373 Free PMC article. Review.

• A novel transgenic mice model for venous malformation.

  Wang YA, Zheng JW, Fei ZL, Jiang XQ, Wang ZG, Fei J, Zhang ZY. Wang YA, et al. Transgenic Res. 2009 Apr;18(2):193-201. doi: 10.1007/s11248-008-9224-1. Epub 2008 Oct 14. Transgenic Res. 2009. PMID: 18853270

• Current status of transcriptional regulation systems.

  May T, Hauser H, Wirth D. May T, et al. Cytotechnology. 2006 Mar;50(1-3):109-19. doi: 10.1007/s10616-006-9007-6. Epub 2006 May 20. Cytotechnology. 2006. PMID: 19003074 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information